Fresenius Medcare: stock up on broker's comments
(CercleFinance.com) - The Fresenius Medical Care share is up 1% in Frankfurt today, helped by Jefferies which upgraded its rating to "buy," with a target price of 80 euros, after updating its medium-term investment case for the share and judging that the market is not crediting the group for its home care strategy.
"NT uncertainties, especially around guidance on Feb 20, we believe any market volatility at FY could provide an entry point for LT investors focused on ROIC," the broker said.
Copyright (c) 2020 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
"NT uncertainties, especially around guidance on Feb 20, we believe any market volatility at FY could provide an entry point for LT investors focused on ROIC," the broker said.
Copyright (c) 2020 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.